MC3 Cardiopulmonary said it acquired Terumo Corp.‘s (TYO:4543) surgical cannula assets, including its branded Sarns Soft-Flow arterial cannula.

Dexter, Mich.-based MC3 Cardiopulmonary spun-out of the University of Michigan in 1991 and focuses on heart and lung extracorporeal life support research, the company said.

“This is a significant milestone for us, and we are excited to return the legacy of Soft-Flow arterial cannula to the users and patients it will serve. In order to support our goals as a global medical device company we have built a world-class facility just outside of Ann Arbor in Dexter, Michigan. The location provides close proximity to the University of Michigan, Detroit International Airport and skilled knowhow within our sector,” MC3 CEO Scott Merz said in a press release.

Terumo’s surgical cannula portfolio contains more than 200 products, the company said. The flagship product in the line is the Soft-Flow arterial cannula, the 1st dispersion tip aortic cannula according to MC3.

The acquisition will aid MC3 in their goal of becoming a “global cardiopulmonary medical device manufacturer.”